Zarir Udwadia

Efficacy and safety of favipiravir, an oral RNA-dependent RNA polymerase inhibitor, in mild-to-moderate COVID-19: A randomized, comparative, open-label, multicenter, phase 3 clinical trial

Zarir Udwadia, Pawan Singh, Hanmant Barkate et al. · International Journal of Infectious Diseases · 2020 · 291 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +15

Worldwide Effects of Coronavirus Disease Pandemic on Tuberculosis Services, January–April 2020

Giovanni Battista Migliori, Pei Min Thong, Onno W. Akkerman et al. · Emerging infectious diseases · 2020 · 222 citations · Full text

Public Health, Infectious Diseases, Global Health +8

Incidence of Multidrug-Resistant Tuberculosis in Urban and Rural India and Implications for Prevention

Deepak V. Almeida, Camilla Rodrigues, Zarir Udwadia et al. · Clinical Infectious Diseases · 2003 · 91 citations · Full text

Public Health, Infectious Diseases, Urban Health +17

High Incidence of the Beijing Genotype among Multidrug-Resistant Isolates of Mycobacterium tuberculosis in a Tertiary Care Center in Mumbai, India

Deepak V. Almeida, C Rodrigues, Tester F. Ashavaid et al. · Clinical Infectious Diseases · 2005 · 81 citations

Life Sciences, Microbiology, Molecular Genetics +13

Pulmonary manifestations in inflammatory bowel disease: a prospective study

Devendra Desai, Samir Patil, Zarir Udwadia et al. · Indian Journal of Gastroenterology · 2011 · 65 citations

Medicine, Clinical Sciences, Internal Medicine +16